Cryosite Limited logo

Cryosite Limited (CTE)

Market Open
CXA CXA
118.04M Market Cap
21.25 P/E Ratio
- Div Yield
404 Volume
0 Eps
Want to track CTE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CTE is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

Cryosite Limited (CTE) FAQ

On which exchange is it traded?

Cryosite Limited is listed on CXA.

What is its stock symbol?

The ticker symbol is CTE.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 118.04M.

Has Cryosite Limited ever had a stock split?

No, there has never been a stock split.

Cryosite Limited Profile

Professional Services Industry
Industrials Sector
Mr. John Hogg CMILT CEO
CXA Exchange
- ISIN
Australia Country
25 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Cryosite Limited is a specialized provider of outsourced clinical trials logistic services based in Australia. Established in 1999 and headquartered in South Granville, Australia, the company operates across two primary segments: Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. Cryosite serves a diverse range of industries, including research, medical, pharmaceutical, and biotechnology, offering a variety of services tailored to the needs of the clinical trials, research, and pharmaceutical sectors. By focusing on reliable and advanced logistic solutions, Cryosite has positioned itself as a critical partner for organizations seeking specialized storage and logistic services in the healthcare and biotechnological fields.

Products and Services

  • Clinical Trials and Biological Services Logistics

    Under this segment, Cryosite offers extensive logistic services tailored to the clinical trials, research, and pharmaceutical industries. This includes specialist temperature-controlled storage to ensure the integrity of sensitive materials. The company also provides sourcing, labelling, and secondary packaging services, which are crucial for the safe and secure transportation of clinical materials. Status management and schedule drug distribution services ensure timely and efficient delivery of medical products, while destruction and returns processes handle the disposal and return of clinical trial materials. Additionally, Cryosite extends its biological logistics services, supporting the complex needs of biological transportation and storage with proficiency.

  • Cord Blood and Tissues Storage

    This segment caters to the need for long-term storage solutions for cord blood and tissue samples. Cryosite’s dedicated storage facilities are designed to maintain the viability of these samples for future medical or research purposes, leveraging advanced technology and stringent safety measures to ensure the preservation of these critical biological materials. This service is particularly vital for families and individuals looking to store stem cells and other tissues for potential future health treatments, providing a form of biological insurance against certain medical conditions.

Contact Information

Address: 13a Ferndell Street
Phone: 61 2 8865 2000